Abstract
New approaches to control tuberculosis (TB) worldwide are needed. In particular, new tools for diagnosis and new biomarkers are required to evaluate both pathogen and host key elements of the response to infection. Non-sputum based diagnostic tests, biomarkers predictive of adequate responsiveness to treatment, and biomarkers of risk of developing active TB disease are major goals. Here, we review the current state of the field. Although reports on new candidate biomarkers are numerous, validation and independent confirmation are rare. Efforts are needed to reduce the gap between the exploratory up-stream identification of candidate biomarkers, and the validation of biomarkers against clear clinical endpoints in different populations. This will need a major commitment from both scientists and funding bodies.
Highlights
Non-sputum based diagnostic tests, biomarko ers predictive of adequate responsiveness to treatment, and biomarkers of risk of develope ing active TB disease are major goals
Mycobacterium tuberculosis (Mtb) DNA can be detected in blood and urine of m pulmonary TB patients with a better sensitivity o than Mtb culture from the same biological fluid.[25,26,27]
This study suggested a possible role of specific subsets of CD4+ T-cells in the containment of ly Mtb and raises interesting questions on the possible role of these cells
Summary
Non-sputum based diagnostic tests, biomarko ers predictive of adequate responsiveness to treatment, and biomarkers of risk of develope ing active TB disease are major goals.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.